about
A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural AlertsHepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.Antidepressant-induced hepatotoxicity.Antidepressant-induced liver injury.The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacologyDrug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.Idiosyncratic drug hepatotoxicity.Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity.Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.Liver Illness and Psychiatric Patients.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.Hepatotoxicity, leucopenia and neutropenia associated with olanzapine therapy.Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells.Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays.Cytoprotective Effects of Melatonin Against Amitriptyline-Induced Toxicity in Isolated Rat Hepatocytes.Alterations of liver function test in patients treated with antipsychotics.Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications.Preventive effects of fructose and N-acetyl-L-cysteine against cytotoxicity induced by the psychoactive compounds N-methyl-5-(2-aminopropyl)benzofuran and 3,4-methylenedioxy-N-methamphetamine in isolated rat hepatocytes.Metabolism of [14C]-5-chloro-1,3-benzodioxol-4-amine in male Wistar-derived rats following intraperitoneal administration
P2860
Q28820944-CD150440-6721-43B4-9FD8-E2DA78BDEA41Q30887490-25597505-6FB5-4201-8311-D578E4E1E8D6Q34536009-01BCA9B0-AE2C-426F-AB6C-56A96B102AF8Q34580845-7FE14FFA-C220-4BA3-8015-CDCF09FF7DD7Q34608619-7C516D4C-8458-4081-B369-64D8BFDF8F41Q35809210-B161BD8B-6447-4116-9163-7A7F0DBCEC41Q36148442-8D030197-F789-47ED-B919-1C05BE808489Q36302732-DB4B2627-30C9-4F0E-B192-8867D8D4D846Q37441580-A14E263A-EF86-404A-9537-6C6E511FBA03Q37587062-120BFB2E-6A4F-454D-9836-120564F89957Q37625519-A7E3DA54-ABCE-4A4E-9DA7-83784E316A14Q37718523-24FB8649-5606-4D94-9934-C2DF9DD9112BQ38221195-C63196CF-9B50-4CED-9FDD-3C0CE6FBA914Q38827021-E270BC1A-2ECB-4D20-8CA1-1B763C08854DQ38838664-7A48FE92-2F8D-4DCE-9274-742956BA3960Q39240382-DE6EA36B-07DC-42FD-9F77-A625FBE24E3DQ42505249-68F8F5D8-CC18-49E4-BAAC-23863E183D52Q43205217-24EE2C3E-A57F-46D3-BC6E-D11794CE6428Q44653929-1175A0F6-0058-4F67-8846-E7330161ECB6Q46632134-77D29061-2A21-4EAE-B435-14CA998EF8F3Q48053078-D89A8913-5841-44D6-A8EE-C8B7A391A56EQ58045855-F502E1DD-64A1-4D66-86EF-DF89B7E09C4A
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hepatotoxicity of psychotropic drugs.
@ast
Hepatotoxicity of psychotropic drugs.
@en
type
label
Hepatotoxicity of psychotropic drugs.
@ast
Hepatotoxicity of psychotropic drugs.
@en
prefLabel
Hepatotoxicity of psychotropic drugs.
@ast
Hepatotoxicity of psychotropic drugs.
@en
P356
P1433
P1476
Hepatotoxicity of psychotropic drugs.
@en
P2093
P304
P356
10.1002/HEP.510290535
P407
P577
1999-05-01T00:00:00Z